Skip to main content

Day: November 18, 2025

MiniLuxe Expands Franchise Network with Third Multi-Unit Partner in Fairfield County, Connecticut

Boston, MA, Nov. 18, 2025 (GLOBE NEWSWIRE) — MiniLuxe Holding Corp. (TSXV: MNLX) — MiniLuxe, the pioneer in clean nail care and ethical nail services, announced today that Vera Lexmond has signed a three-location franchise development agreement to bring the MiniLuxe brand and experience to Fairfield County, Connecticut, with the first location opening targeted before the end of next year. Lexmond becomes the third multi-unit franchise developer to join MiniLuxe’s growing network, following Quynh Pham in Brookline, MA, and Peiru Kim in Tampa, Florida. Her commitment marks another significant milestone in the company’s thoughtful national rollout of its franchise program, which has seen strong inbound interest since its launch. This franchise operating partnership aligns with MiniLuxe’s ongoing focus to scale in a capital-efficient...

Continue reading

Sprout Social Unveils Trellis, its AI Agent That Turns Social Data Into Instant Enterprise Intelligence

Sprout AI delivers the company’s most significant intelligence update yet, enabling organizations to proactively manage brand reputation, unlock strategic capacity and deliver high-impact content. Trellis, Sprout’s new proprietary AI Agent, provides conversational data exploration, reveals insights, and recommended actions based on billions of social data points. This release also enables Sprout to connect with leading AI providers, starting with ChatGPT, helping organizations embed real-time social data directly into key business workflows.CHICAGO, Nov. 18, 2025 (GLOBE NEWSWIRE) — Sprout Social (Nasdaq: SPT), an industry-leading provider of social media management and analytics software, today launched Sprout AI—the company’s most significant intelligence update—anchored by its new proprietary AI Agent, Trellis. Trellis...

Continue reading

Wearable Devices Unveils EMG-Based Weight Estimation Technology, Advancing Its Neural-Interface IP Into Pre-Commercial Development

Yokneam Illit, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (the “Company” or “Wearable Devices”), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced that it has successfully implemented and demonstrated a pre-commercial electromyography (“EMG”)-driven weight-estimation capability running on its Mudra Link neural wristband, based on its recently secured patent for weight, torque and force estimation. This achievement represents a significant advancement in the Company’s neuromuscular computing roadmap. This development is part of Wearable Devices’ ongoing research and development efforts, aimed at harnessing neuromuscular-signals-based technology to support new advanced capabilities across multiple industries. Leveraging...

Continue reading

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Vancouver, Canada, Nov. 18, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced positive top-line results from the first cohort of its Phase I/IIa clinical trial evaluating CMND-100, the Company’s proprietary non-hallucinogenic MEAI-based oral drug candidate for the treatment of Alcohol Use Disorder (AUD).  The top-line data from the first cohort demonstrate a favorable safety profile, with no serious adverse events reported and the treatment generally well-tolerated across all participants. Additionally, the cohort showed strong treatment observance, with high adherence to the dosing regimen...

Continue reading

AIM ImmunoTech Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Across Pipeline with Strategic Focus on Pancreatic Cancer Clinical Program

OCALA, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today provided a business update and reported its financial results for the third quarter 2025. “The third quarter was marked by solid and positive clinical and operational execution. Our clinical, manufacturing and regulatory teams are heavily focused on moving Ampligen down a pathway toward eventual FDA approval as part of a combination therapy for pancreatic cancer. We recently reported positive mid-year safety and efficacy data in the ongoing DURIPANC clinical trial combining Ampligen and AstraZeneca’s anti-PD-L1 immune checkpoint inhibitor Imfinzi – or durvalumab – in the treatment of metastatic pancreatic cancer and, as an important inflection point, we will release a year-end update by the end of the current quarter....

Continue reading

Liberty Star Minerals Announces Strategic Corporate Alignment of Mining Claims

New Structure Enhances Clarity, Asset Differentiation, and Partnership Opportunities TUCSON, AZ, Nov. 18, 2025 (GLOBE NEWSWIRE) — Liberty Star Minerals (“Liberty Star” or the “Company”) (OTCQB: LBSR) today announced a strategic realignment of its mining claims and mineral assets. This initiative is designed to enhance operational clarity, differentiate high-value assets, and expand opportunities for strategic partnerships across the Company’s diversified mineral portfolio. Key Highlights of the Alignment:Centralized Oversight of All Mineral AssetsAll mineral holdings will now be consolidated under Liberty Star Hay Mountain Holdings LLC, strengthening organizational clarity and long-term strategic focus. Earp Ridge Mines, LLCThe multi-mineral claims historically known as Hay Mountain Target 1 & 2 will now be structured within,...

Continue reading

Itron Expands Presence in United Kingdom Water Sector with New Cyble™ 5 Contract

Northumbrian Water to Deploy 330,000 Itron Water Endpoints by 2029 in the Northeast Region LIBERTY LAKE, Wash., Nov. 18, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, is collaborating with Northumbrian Water Limited (NWL), a leading water provider in northeast England, to modernize the utility’s water distribution system. NWL will deploy 330,000 Itron Aquadis+ volumetric water meters equipped with Cyble 5 multi-connectivity communication modules by 2029 to easily and efficiently capture accurate data and manage their water network. The collaboration with NWL marks Itron’s third Cyble 5 contract in the U.K, highlighting Itron’s momentum and growing presence in the U.K. water sector. Water utilities in the U.K. are subject to strict water leak...

Continue reading

Micropolis Robotics Unveils New Industrial-Grade, IP67-Rated Computing Module Powered by NVIDIA for Advanced AI Processing of its Robots

High-performance, low-latency AI processing will be installed directly on Microspot, Micropolis’ proprietary real-time surveillance, behavior-analysis, and mission-management platform Micropolis has been a member of the NVIDIA Inception Program since 2022 DUBAI, United Arab Emirates, Nov. 18, 2025 (GLOBE NEWSWIRE) — Micropolis Holding Co. (“Micropolis” or the “Company”) (NYSE: MCRP), a leading UAE-based developer of autonomous mobile robots and AI-driven security solutions, announced the launch of a new industrial-grade, IP67-rated Edge Computing Unit (“ECU”) powered by NVIDIA Orin SOC. The ECU delivers high-performance, low-latency Artificial Intelligence (“AI”) processing directly on Microspot, Micropolis’ proprietary real-time surveillance, behavior-analysis, and mission-management platform. A member of the NVIDIA Inception...

Continue reading

Euroseas Ltd. Reports Results for the Quarter and Nine-Month Period Ended September 30, 2025, Declares Quarterly Dividend and Announces Multi-Year Forward Charters for Five of Its Vessels Including its Four Vessels Under Construction

ATHENS, Greece, Nov. 18, 2025 (GLOBE NEWSWIRE) — Euroseas Ltd. (NASDAQ: ESEA, the “Company” or “Euroseas”), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today its results for the three and nine-month periods ended September 30, 2025. Third Quarter 2025 Financial Highlights:Total net revenues of $56.9 million. Net income of $29.7 million or $4.27 and $4.25 earnings per share basic and diluted, respectively. Adjusted net income1 for the period was $29.6 million or $4.26 and $4.23 per share basic and diluted. Adjusted EBITDA1 was $38.8 million.An average of 22.0 vessels were owned and operated during the third quarter of 2025 earning an average time charter equivalent rate of $29,284 per day.Declared a quarterly dividend of $0.70 per share for...

Continue reading

Accelerating the Global Commercialization of AR Waveguide Technology with AAC Technologies

Dispelix I AAC TechnologiesAccelerating the Global Commercialization of AR Waveguide Technology with AAC TechnologiesEspoo, Finland, Nov. 18, 2025 (GLOBE NEWSWIRE) — AAC Technologies Pte. Ltd. (the “AAC”), a world-leading smart device solution provider and a company incorporated in Singapore and a fully-owned subsidiary of AAC Technologies Holdings Inc., whose shares are listed and traded on the Hong Kong Stock Exchange, has signed a definitive agreement to acquire the shares and other equity securities in Dispelix Oy, a technology leader in diffractive waveguide displays for augmented reality (AR). The transaction is expected to close within the first half of 2026; upon completion Dispelix will become a subsidiary of AAC. This acquisition builds on a long-standing strategic relationship between Dispelix and AAC, developed...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.